Zhitong Financial App News, Hanson Pharmaceuticals (03692.HK) issued an announcement. On October 17, 2026, the company's wholly-owned subsidiaries Shanghai Hanson Biomedical Technology Co., Ltd., Changzhou Hengbang Pharmaceutical Co., Ltd., and Hansoh Bio, LLC (collectively “Hanson”), and F. Hoffmann-La Roche Ltd (Roche) entered into a strategic partnership and licensing agreement.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.